COVID-19 GPH|Home|PHGKB

Last data update: May 30, 2023 . (Total: 45340 Documents since 2020)

Filtered By:

Query Trace: recent[original query]
Tally of covid-19 cases after CDC conference climbs to 181 Sun LH. Washington Post, May 26, 2023.
Quantification of SARS-CoV-2 spike protein expression from mRNA vaccines using isotope dilution mass spectrometry. William J H Sutton et al. Vaccine 2023 5
Tracking the prevalence and emergence of SARS CoV2 variants of concern using a regional genomic surveillance program. Ana Jung et al. medRxiv 2023 5
Droplet digital recombinase polymerase amplification for multiplexed detection of human coronavirus. Ji Wook Choi et al. Lab Chip 2023 4 (10) 2389-2398
SARS-CoV-2 Delta variant genomic variation associated with breakthrough infection in Northern California: A retrospective cohort study. Jacek Skarbinski et al. J Infect Dis 2023 5
First Round of External Quality Assessment Scheme for SARS-CoV-2 Laboratories During the COVID-19 Pandemic in Thailand. Siriphan Saeng-Aroon et al. Health Secur 2023 5
The importance of equally accessible genomic surveillance in the age of pandemics. Safia Zeghbib et al. Biol Futur 2023 5 1-9
Unsupervised machine learning framework for discriminating major variants of concern during COVID-19. Rohitash Chandra et al. PLoS One 2023 5 (5) e0285719
Tracking SARS-CoV-2 introductions in Mozambique using pandemic-scale phylogenies: a retrospective observational study. Francisco José Martínez-Martínez et al. Lancet Glob Health 2023 5 (6) e933-e941
SARS-CoV-2 Variants Show Different Host Cell Proteome Profiles With Delayed Immune Response Activation in Omicron-Infected Cells. Melinda Metzler et al. Mol Cell Proteomics 2023 3 (5) 100537
Online Phylogenetics with matOptimize Produces Equivalent Trees and is Dramatically More Efficient for Large SARS-CoV-2 Phylogenies than de novo and Maximum-Likelihood Implementations. Alexander M Kramer et al. Syst Biol 2023 5
A Web Tool to Estimate Baseline Anti-Spike Monoclonal Antibody Efficacy Based on Regional Genomic Surveillance. Daniele Focosi et al. Viruses 2023 5 (5)
Why the world needs more transparency on the origins of novel pathogens M Venter, Nature, May 30, 2023 Platforms such as GISAID (the Global Initiative on Sharing All Influenza Data) have enabled important sequencing data to be shared by scientists, with the aim of also protecting researchers’ intellectual property. However, users of these data need to work more closely with the data owners to maintain trust and ensure that sharing continues in the future. Most importantly, we urge scientists and governments to make available all data, research and reports that can help in the identification of the origins of novel pathogens for all outbreaks, epidemics and global health emergencies.
SARS-CoV-2 N-Antigen Quantification in Respiratory Tract, Plasma and Urine: Kinetics and Association with RT-qPCR Results. Parraud Delphine, et al. Viruses 2023 0 0. (5)
Prior SARS-CoV-2 infection and COVID-19 vaccine effectiveness against outpatient illness during widespread circulation of SARS-CoV-2 Omicron variant, US Flu VE network. Tartof Sara Y, et al. Influenza and other respiratory viruses 2023 0 0. (5) e13143
Comparison of the risk of hospitalisation among BA.1 and BA.2 COVID-19 cases treated with sotrovimab in the community in England. Harman Katie, et al. Influenza and other respiratory viruses 2023 0 0. (5) e13150
In Silico Evaluation of SARS-CoV-2 K417N, L452R, and E484K Detection Assays Against Omicron Variants. Sayan Murat, et al. The new microbiologica 2023 0 0. (2) 133-140
Effectiveness of mRNA and inactivated COVID-19 vaccines: a test-negative study in an infection-naïve Hong Kong population. Ng Rita Wy, et al. The Journal of infection 2023 0 0.
Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomes. Mondi Annalisa, et al. Journal of medical virology 2023 0 0. (6) e28831

Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.

Public Health Genomics and Precision Health Knowledge Base (v8.6)

File Formats Help: